# Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding

> **NCT00331188** · PHASE3 · COMPLETED · sponsor: **Debiovision** · enrollment: 70 (actual)

## Conditions studied

- Esophageal Varices
- Portal Hypertension
- Gastric Varices
- Esophageal Bleeding

## Interventions

- **DRUG:** Sanvar® (vapreotide)

## Key facts

- **NCT ID:** NCT00331188
- **Lead sponsor:** Debiovision
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2008-06
- **Final completion:** 2008-07
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2008-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00331188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00331188, "Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00331188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*